Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Proteasome and proteolysis].

David Papapostolou1, Michèle Reboud-Ravaux

  • 1Laboratoire d Enzymologie Moléculaire et Fonctionnelle, Département de Biologie, Institut Jacques Monod, UMR 7592, CNRS-Universités Paris 6 & 7, Tour 43, 2, place Jussieu, 75251 Paris Cedex 05, France.

Journal De La Societe De Biologie
|January 25, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Protein induced proximity and targeted degradations by new degraders: concepts, developments, challenges for clinical applications].

Biologie aujourd'hui·2024
Same author

Biologie aujourd'hui·2022
Same author

The HIV-1 Nucleocapsid Regulates Its Own Condensation by Phase-Separated Activity-Enhancing Sequestration of the Viral Protease during Maturation.

Viruses·2021
Same author

[The proteasome - structural aspects and inhibitors: a second life for a validated drug target].

Biologie aujourd'hui·2021
Same author

[Induced degradation of proteins by PROTACs and other strategies: towards promising drugs].

Biologie aujourd'hui·2021
Same author

Structural Studies on the Inhibitory Binding Mode of Aromatic Coumarinic Esters to Human Kallikrein-Related Peptidase 7.

Journal of medicinal chemistry·2020
Same journal

[Food safety of GMOs].

Journal de la Societe de biologie·2010
Same journal

[Placing on the market, breeders rights and growing genetically modified (GM) varieties].

Journal de la Societe de biologie·2010
Same journal

[Cultivation and environmental impacts of GMO crops].

Journal de la Societe de biologie·2010
Same journal

[Applications of genetically modified animals].

Journal de la Societe de biologie·2010
Same journal

[Why GMOs].

Journal de la Societe de biologie·2010
Same journal

[Mutations in renin-angiotensin system genes and kidney developmental anomalies].

Journal de la Societe de biologie·2010
See all related articles

Cellular protein degradation, essential for homeostasis, relies on the 26S proteasome. Proteasome inhibitors, like Velcade, are crucial tools for studying this enzyme and have entered clinical trials for cancer treatment.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Context:

  • Cellular homeostasis and environmental response depend on protein degradation.
  • The 26S proteasome is critical for degrading bulk and regulatory proteins.
  • This enzyme regulates key cellular processes including cell cycle and apoptosis.

Purpose:

  • To highlight the essential role of the 26S proteasome in cellular functions.
  • To introduce the development and utility of proteasome inhibitors.
  • To note the clinical application of proteasome inhibitors in cancer therapy.

Summary:

  • The 26S proteasome is a vital multicatalytic enzyme complex responsible for protein turnover.
  • Its unique mechanism and involvement in cellular regulation underscore its biological significance.

Related Experiment Videos

  • Proteasome inhibitors, exemplified by Velcade (bortezomib), aid in understanding proteasome function and have therapeutic potential.

    • Impact:

    • Elucidating the biological roles of the 26S proteasome through inhibitor studies.
    • Advancing cancer treatment strategies with the development of proteasome inhibitors.
    • Providing insights into fundamental cellular mechanisms governing protein degradation and homeostasis.